Antifibrotics improve quality of life in idiopathic pulmonary fibrosis: Study Dr. Kamal Kant Kohli28 Oct 2022 2:45 PM GMTDENMARK: In terms of enhancing survival, treatment with nintedanib and pirfenidone was preferred to no antifibrotic medication, regardless of the...
Nintedanib slows lung disease progression in systemic sclerosis over 100 weeks: SENSCIS trial Medha Baranwal26 July 2022 2:30 PM GMTUSA: Nintedanib provided a sustained benefit of slowing systemic sclerosis-associated interstitial lung disease (SSc-ILD) progression over 100 weeks...
Nintedanib found effective for drug resistant gastrointestinal stromal tumors Dr. Kamal Kant Kohli15 April 2022 2:00 PM GMTNintedanib could be used in the treatment of drug-resistant gastrointestinal stromal tumors (GISTs), finds a research led by Prof. LIU Qingsong and...
Nintedanib benefits patients with autoimmune disease-related lung diseases Hina Zahid12 March 2022 3:30 AM GMTA new clinical published in Arthritis & Rheumatology reveals that nintedanib, a medication that helps prevent changes to lung tissue, may help...
Promising Benefits of Nintedanib in Minimizing COVID Induced Lung Injury in mechanically ventilated patients: Results from a Pilot Study Dr. JUDO JOSEPH VACHAPARAMBIL11 Sep 2021 7:15 AM GMTNew Delhi: The COVID-19 pandemic has been unrelenting for the last year and a half. Globally, increasing numbers are added each day to the COVID-19...
JB Chemicals and Pharmaceuticals launches Nintedanib for treatment in Idiopathic Pulmonary Fibrosis (IPF) Meghna A Singhania26 Jun 2021 5:36 AM GMTMumbai: J.B. Chemicals & Pharmaceuticals Ltd. today announced the launch of 'Nintabid' Capsules containing Nintedanib 100mg and 150mg, an oral...
Cipla launches generic Idiopathic Pulmonary Fibrosis drug Nintedanib in India Ruchika Sharma21 Oct 2020 7:30 AM GMTNew Delhi: Pharma major Cipla on Tuesday said it has launched generic Nintedanib used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) under...
BDR Pharma unveils idiopathic pulmonary fibrosis drug Nintedanib in India Ruchika Sharma20 Oct 2020 5:36 AM GMTIPF is lung disorder where there is scarring of the lungs due to an unknown cause, BDR Pharmaceuticals said in a statement.
